Search

Search Constraints

You searched for: Author/Creator Hill, Rebecca M

Search Results

1. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study. (February 2020)

2. Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse. Issue 1 (17th July 2021)

3. MBCL-30. SUBGROUP-DIRECTED CLINICAL AND MOLECULAR STRATIFICATION OF DISEASE RISK IN INFANT MEDULLOBLASTOMA. Issue 2 (22nd June 2018)

4. MBRS-10. QUIESCENT SOX9-POSITIVE CELLS BEHIND MYC DRIVEN MEDULLOBLASTOMA RECURRENCE. (4th December 2020)

5. MBRS-60. THE ACTIONABLE GENOMIC LANDSCAPE OF RELAPSED MEDULLOBLASTOMA IS DEFINED BY MAINTENANCE AND ACQUISITION OF DRIVER EVENTS. (4th December 2020)

6. MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse. (3rd June 2022)

7. MEDB-71. Molecular characterisation of group 4 medulloblastoma improves risk-stratification and its biological understanding. (3rd June 2022)

8. MEDB-79. MYC-driven upregulation of thede novo serine and glycine pathway is a novel therapeutic target for Group 3 MYC-amplified Medulloblastoma. (3rd June 2022)

9. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Issue 7 (July 2017)